ACCF/SCAI/SVMB/SIR?ASITN 2007 clinical expert consensus document on carotid stenting

Vascular Medicine

Volumn 12, Issue 1, 2007, Pages 35-83

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; ATENOLOL; ATORVASTATIN; ATROPINE; CILOSTAZOL; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; DOPAMINE; GEMFIBROZIL; LOSARTAN; NICOTINIC ACID; PERINDOPRIL; PHENYLEPHRINE; PLACEBO; PRAVASTATIN; RAMIPRIL; SIMVASTATIN; TICLOPIDINE; WARFARIN;

ACCREDITATION; ARTERY EMBOLISM; ARTICLE; BLEEDING; BRAIN ANGIOGRAPHY; BRAIN BLOOD VESSEL; BRAIN HEMORRHAGE; CAROTID ARTERIOGRAPHY; CAROTID ARTERY DISEASE; CAROTID ARTERY SURGERY; CAROTID ENDARTERECTOMY; CEREBRAL REVASCULARIZATION; CEREBROVASCULAR DISEASE; CLINICAL ASSESSMENT; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONSENSUS DEVELOPMENT; DOPPLER ECHOGRAPHY; DRUG DOSE COMPARISON; DRUG MEGADOSE; DRUG TREATMENT FAILURE; HUMAN; LOW DRUG DOSE; MAGNETIC RESONANCE ANGIOGRAPHY; MEDICAL DECISION MAKING; MEDICAL EDUCATION; META ANALYSIS; MONOTHERAPY; NEUROANATOMY; NEUROPHYSIOLOGY; NEUTROPENIA; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; RISK ASSESSMENT; STENT; STROKE; SURGICAL TECHNIQUE; SURGICAL TRAINING; SYSTEMATIC REVIEW; TREATMENT CONTRAINDICATION; TREATMENT INDICATION;

EID: 34247141816     PISSN: 1358863X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1358863X06076103     Document Type: Article

References (229)

1. Thom T, Haase N, Rosamond W et al. Heart disease and stroke statistics - 2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006; 113: e85-151.
2. Kleindorfer D, Panagos P, Pancioli A et al. Incidence and short-term prognosis of transient ischemic attack in a population-based study. Stroke 2005; 36: 720-3.
3. White H, Boden-Albala B, Wang C et al. Ischemic stroke subtype incidence among whites, blacks, and Hispanics: the Northern Manhattan Study. Circulation 2005; 111: 1327-31.
4. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991; 337: 1521-6.
5. Gorelick PB. Distribution of atherosclerotic cerebrovascular lesions. Effects of age, race, and sex. Stroke 1993; 24: I16-9.
6. Sacco RL, Kargman DE, Gu Q, Zamanillo MC. Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study. Stroke 1995; 26: 14-20.
7. Wityk RJ, Lehman D, Klag M et al. Race and sex differences in the distribution of cerebral atherosclerosis. Stroke 1996; 27: 1974-80.
8. Bogousslavsky J, Van MG, Regli F. The Lausanne Stroke Registry: analysis of 1,000 consecutive patients with first stroke. Stroke 1988; 19: 1083-92.
9. Foulkes MA, Wolf PA, Price TR et al. The Stroke Data Bank: design, methods, and baseline characteristics. Stroke 1988; 19: 547-54.
10. Inzitari D, Eliasziw M, Gates P et al. The causes and risk of stroke in patients with asymptomatic internal-carotid-artery stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 2000; 342: 1693-700.
11. Timsit SG, Sacco RL, Mohr JP et al. Early clinical differentiation of cerebral infarction from severe atherosclerotic stenosis and cardioembolism. Stroke 1992; 23: 486-91.
12. Osborn AG. Diagnostic cerebral angiography. 2nd edn. 1999: Philadelphia, PA: Williams and Wilkins.
13. Casserly IP, Yadav JS. Carotid intervention. In: Casserly IP, Sachar R, Yadav JS, eds. Manual of Peripheral Vascular Intervention, Philadelphia, PA: Lippincott Williams & Wilkins, 2005: 83-109.
14. Schneider P. Advanced cerebrovascular arteriography: applications in carotid stenting. In: Schneider P, Bohannon W, Silva M, eds. Carotid Interventions. New York, NY: Marcel Dekker, 2004: 69-91.
15. Mohr JP, Gautier J. Internal carotid artery disease. In: Mohr JP, ed. Stroke: Pathophysiology, Diagnosis, and Management. Philadelphia, PA: Churchill Livingstone, 2004: 75-200.
16. Cho L, Mukherjee D. Basic cerebral anatomy for the carotid interventionalist: The intracranial and extracranial vessels. Catheter Cardiovasc Interv 2006; 68: 104-11.
17. White CJ, Ramee SR, Bendick PJ, Safian RD. Peripheral vascular intervention: The Manual of Interventional Cardiology. 3rd edn. Royal Oak, MI: Physician' s Press, 2001: 831-901.
18. O' Leary DH, Polak JF, Kronmal RA et al. Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study. The CHS Collaborative Research Group. Stroke 1992; 23: 1752-60.
19. Muluk SC, Muluk VS, Sugimoto H et al. Progression of asymptomatic carotid stenosis: a natural history study in 1004 patients. J Vasc Surg 1999; 29: 208-14.
20. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991; 325: 445-53.
21. Barnett HJ, Taylor DW, Eliasziw M et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1998; 339: 1415-25.
22. Rothwell PM, Warlow CP, on behalf of the European carotid surgery trialists' collaborative group. Low risk of ischemic stroke in patients with reduced internal carotid artery lumen diameter distal to severe symptomatic carotid stenosis: cerebral protection due to low poststenotic flow? Stroke 2000; 31: 622-30.
23. Morgenstern LB, Fox AJ, Sharpe BL et al. The risks and benefits of carotid endarterectomy in patients with near occlusion of the carotid artery. North American Symptomatic Carotid Endarterectomy Trial (NASCET) Group. Neurology 1997; 48: 911-5.
24. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA 1995; 273: 1421-8.
25. Halliday A, Mansfield A, Marro J et al. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet 2004; 363: 1491-502.
26. Eagle, KA, Guyton, RA, Davidoff R et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery) Available at: http://www.cardiosource.com/ guidelines/browse.asp?topicID=7.
27. Benavente O, Eliasziw M, Streifler JY et al. Prognosis after transient monocular blindness associated with carotid-artery stenosis. N Engl J Med 2001; 345: 1084-90.
28. Kappelle LJ, Eliasziw M, Fox AJ, Sharpe BL, Barnet HJ. Importance of intracranial atherosclerotic disease in patients with symptomatic stenosis of the internal carotid artery. The North American Symptomatic Carotid Endarterectomy Trial. Stroke 1999; 30: 282-6.
29. Vernieri F, Pasqualetti P, Matteis M et al. Effect of collateral blood flow and cerebral vasomotor reactivity on the outcome of carotid artery occlusion. Stroke 2001; 32: 1552-8.
30. Gasecki AP, Eliasziw M, Ferguson GG et al. Long-term prognosis and effect of endarterectomy in patients with symptomatic severe carotid stenosis and contralateral carotid stenosis or occlusion: results from NASCET. North American Symptomatic Carotid Endarterectomy Trial (NASCET) Group. J Neurosurg 1995; 83: 778-82.
31. Henderson RD, Eliasziw M, Fox AJ et al. Angiographically defined collateral circulation and risk of stroke in patients with severe carotid artery stenosis. North American Symptomatic Carotid Endarterectomy Trial (NASCET) Group. Stroke 2000; 31: 128-32.
32. Polak JF, Shemanski L, O'Leary DH et al. Hypoechoic plaque at US of the carotid artery: an independent risk factor for incident stroke in adults aged 65 years or older. Cardiovascular Health Study. Radiology 1998; 208: 649-54.
33. Mathiesen EB, Bonaa KH, Joakimsen O. Echolucent plaques are associated with high risk of ischemic cerebrovascular events in carotid stenosis: the tromso study. Circulation 2001; 103: 2171-5.
34. Sitzer M, Muller W, Siebler M et al. Plaque ulceration and lumen thrombus are the main sources of cerebral microemboli in high-grade internal carotid artery stenosis. Stroke 1995; 26: 1231-3.
35. Streifler JY, Eliasziw M, Fox AJ et al. Angiographic detection of carotid plaque ulceration. Comparison with surgical observations in a multicenter study. North American Symptomatic Carotid Endarterectomy Trial. Stroke 1994; 25: 1130-2.
36. Johnston SC, Gress DR, Browner WS, Sidney S. Short-term prognosis after emergency department diagnosis of TIA. JAMA 2000; 284: 2901-6.
37. Lyden P, Raman R, Liu L et al. NIHSS training and certification using a new digital video disk is reliable. Stroke 2005; 36: 2446-9.
38. Muir KW, Weir CJ, Murray GD et al. Comparison of neurological scales and scoring systems for acute stroke prognosis. Stroke 1996; 27: 1817-20.
39. European Carotid Surgery Trialists' Collaborative Group. MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. Lancet 1991; 337: 1235-43.
40. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet 1998; 351: 1379-87.
41. Sabeti S, Schillinger M, Mlekusch W et al. Quantification of internal carotid artery stenosis with duplex US: comparative analysis of different flow velocity criteria. Radiology 2004; 232: 431-9.
42. Bray JM, Galland F, Lhoste P et al. Colour Doppler and duplex sonography and angiography of the carotid artery bifurcations. Prospective, double-blind study. Neuroradiology 1995; 37: 219-24.
43. Bluth EI, Sunshine JH, Lyons JB et al. Power Doppler imaging: initial evaluation as a screening examination for carotid artery stenosis. Radiology 2000; 215: 791-800.
44. Lovett JK, Redgrave JN, Rothwell PM. A critical appraisal of the performance, reporting, and interpretation of studies comparing carotid plaque imaging with histology. Stroke 2005; 36: 1091-7.
45. Rothwell PM, Gibson R, Warlow CP, on behalf of the European Carotid Surgery Trialists' Collaborative Group. Interrelation between plaque surface morphology and degree of stenosis on carotid angiograms and the risk of ischemic stroke in patients with symptomatic carotid stenosis. Stroke 2000; 31: 615-21.
46. Biasi GM, Froio A, Diethrich EB et al. Carotid plaque echolucency increases the risk of stroke in carotid stenting: the Imaging in Carotid Angioplasty and Risk of Stroke (ICAROS) study. Circulation 2004; 110: 756-62.
47. Kastelein JJ, de Groot E, Sankatsing R. Atherosclerosis measured by B-mode ultrasonography: effect of statin therapy on disease progression. Am J Med 2004; 116(Suppl 6A): 31S-6S.
48. Hodis HN, Mack WJ, LaBree L et al. The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med 1998; 128: 262-9.
49. Blakeley DD, Oddone EZ, Hasselblad V et al. Noninvasive carotid artery testing. A meta-analytic review. Ann Intern Med 1995; 122: 360-7.
50. Grant EG, Benson CB, Moneta GL et al. Carotid artery stenosis: gray-scale and Doppler US diagnosis - Society of Radiologists in ultrasound consensus conference. Radiology 2003; 229: 340-6.
51. Comerota AJ, Salles-Cunha SX, Daoud Y et al. Gender differences in blood velocities across carotid stenoses. J Vasc Surg 2004; 40: 939-44.
52. AbuRahma AF, Robinson PA, Strickler DL et al. Proposed new duplex classification for threshold stenoses used in various symptomatic and asymptomatic carotid endarterectomy trials. Ann Vasc Surg 1998; 12: 349-58.
53. Busuttil SJ, Franklin DP, Youkey JR, Elmore JR. Carotid duplex overestimation of stenosis due to severe contralateral disease. Am J Surg 1996; 172: 144-7.
54. Fujitani RM, Kafie F. Screening and preoperative imaging of candidates for carotid endarterectomy. Semin Vasc Surg 1999; 12: 261-74.
55. Howard G, Baker WH, Chambless LE et al. An approach for the use of Doppler ultrasound as a screening tool for hemodynamically significant stenosis (despite heterogeneity of Doppler performance). A multicenter experience. Asymptomatic Carotid Atherosclerosis Study Investigators. Stroke 1996; 27: 1951-7.
56. Kuntz KM, Polak JF, Whittemore AD, Skillman JJ, Kent KC. Duplex ultrasound criteria for the identification of carotid stenosis should be laboratory specific. Stroke 1997; 28: 597-602.
57. Alexandrov AV. Ultrasound and angiography in the selection of patients for carotid endarterectomy. Curr Cardiol Rep 2003; 5: 141-7.
58. Elgersma OE, van Leersum M, Buijs PC et al. Changes over time in optimal duplex threshold for the identification of patients eligible for carotid endarterectomy. Stroke 1998; 29: 2352-6.
59. Qureshi AI, Suri MF, Ali Z et al. Role of conventional angiography in evaluation of patients with carotid artery stenosis demonstrated by Doppler ultrasound in general practice. Stroke 2001; 32: 2287-91.
60. Akers DL, Markowitz IA, Kerstein MD. The value of aortic arch study in the evaluation of cerebrovascular insufficiency. Am J Surg 1987; 154: 230-2.
61. Sitzer M, Rose G, Furst G et al. Characteristics and clinical value of an intravenous echo-enhancement agent in evaluation of high-grade internal carotid stenosis. J Neuroimaging 1997; 7(Suppl 1): S22-S25.
62. Droste DW, Jurgens R, Weber S et al. Benefit of echocontrast-enhanced transcranial color-coded duplex ultrasound in the assessment of intracranial collateral pathways. Stroke 2000; 31: 920-3.
63. Ferrer JM, Samso JJ, Serrando JR et al. Use of ultrasound contrast in the diagnosis of carotid artery occlusion. J Vasc Surg 2000; 31: 736-41.
64. Paciaroni M, Caso V, Cardaioli G et al. Is ultrasound examination sufficient in the evaluation of patients with internal carotid artery severe stenosis or occlusion? Cerebrovasc Dis 2003; 15: 173-6.
65. Filis KA, Arko FR, Johnson BL et al. Duplex ultrasound criteria for defining the severity of carotid stenosis. Ann Vasc Surg 2002; 16: 413-21.
66. Mattos MA, Hodgson KJ, Faught WE et al. Carotid endarterectomy without angiography: is color-flow duplex scanning sufficient? Surgery 1994; 116: 776-82.
67. Patel MR, Kuntz KM, Klufas RA et al. Preoperative assessment of the carotid bifurcation. Can magnetic resonance angiography and duplex ultrasonography replace contrast arteriography? Stroke 1995; 26: 1753-8.
68. Navarro JC, Mikulik R, Garami Z, Alexandrov AV. The accuracy of transcranial Doppler in the diagnosis of stenosis or occlusion of the terminal internal carotid artery. J Neuroimaging 2004; 14: 314-8.
69. Sloan MA, Alexandrov AV, Tegeler CH et al. Assessment: transcranial Doppler ultrasonography: report of the therapeutics and technology assessment subcommittee of the American academy of neurology. Neurology 2004; 62: 1468-81.
70. Marshall RS, Rundek T, Sproule DM et al. Monitoring of cerebral vasodilatory capacity with transcranial Doppler carbon dioxide inhalation in patients with severe carotid artery disease. Stroke 2003; 34: 945-9.
71. Spence JD, Tamayo A, Lownie SP, Ng WP, Ferguson GG. Absence of microemboli on transcranial Doppler identifies low-risk patients with asymptomatic carotid stenosis. Stroke 2005; 36: 2373-8.
72. Wutke R, Lang W, Fellner C et al. High-resolution, contrast-enhanced magnetic resonance angiography with elliptical centric k-space ordering of supra-aortic arteries compared with selective X-ray angiography. Stroke 2002; 33: 1522-9.
73. Alvarez-Linera J, Benito-Leon J, Escribano J, Campollo J, Gesto R. Prospective evaluation of carotid artery stenosis: elliptic centric contrast-enhanced MR angiography and spiral CT angiography compared with digital subtraction angiography. Am J Neuroradiol 2003; 24: 1012-9.
74. Remonda L, Senn P, Barth A et al. Contrast-enhanced 3D MR angiography of the carotid artery: comparison with conventional digital subtraction angiography. Am J Neuroradiol 2002; 23: 213-9.
75. Cosottini M, Pingitore A, Puglioli M et al. Contrast-enhanced three-dimensional magnetic resonance angiography of atherosclerotic internal carotid stenosis as the noninvasive imaging modality in revascularization decision making. Stroke 2003; 34: 660-4.
76. DeMarco JK, Huston J III, Bernstein MA. Evaluation of classic 2D time-of-flight MR angiography in the depiction of severe carotid stenosis. AJR Am J Roentgenol 2004; 183: 787-93.
77. Long A, Lepoutre A, Corbillon E, Branchereau A. Critical review of non- or minimally invasive methods (duplex ultrasonography, MR- and CT-angiography) for evaluating stenosis of the proximal internal carotid artery. Eur J Vasc Endovasc Surg 2002; 24: 43-52.
78. Buskens E, Nederkoorn PJ, Buijs-Van Der WT et al. Imaging of carotid arteries in symptomatic patients: cost-effectiveness of diagnostic strategies. Radiology 2004; 233: 101-12.
79. Yuan C, Mitsumori LM, Ferguson MS et al. In vivo accuracy of multispectral magnetic resonance imaging for identifying lipidrich necrotic cores and intraplaque hemorrhage in advanced human carotid plaques. Circulation 2001; 104: 2051-6.
80. Rutt BK, Clarke SE, Fayad ZA. Atherosclerotic plaque characterization by MR imaging. Curr Drug Targets Cardiovasc Haematol Disord 2004; 4: 147-59.
81. Glor FP, Ariff B, Crowe LA et al. Carotid geometry reconstruction: a comparison between MRI and ultrasound. Med Phys 2003; 30: 3251-61.
82. Teng MM, Tsai F, Liou AJ et al. Three-dimensional contrast-enhanced magnetic resonance angiography of carotid artery after stenting. J Neuroimaging 2004; 14: 336-41.
83. Gronholdt ML. B-mode ultrasound and spiral CT for the assessment of carotid atherosclerosis. Neuroimaging Clin N Am 2002; 12: 421-35.
84. Belsky M, Gaitini D, Goldsher D, Hoffman A, Daitzchman M. Color-coded duplex ultrasound compared to CT angiography for detection and quantification of carotid artery stenosis. Eur J Ultrasound 2000; 12: 49-60.
85. Hollingworth W, Nathens AB, Kanne JP et al. The diagnostic accuracy of computed tomography angiography for traumatic or atherosclerotic lesions of the carotid and vertebral arteries: a systematic review. Eur J Radiol 2003; 48: 88-102.
86. Koelemay MJ, Nederkoorn PJ, Reitsma JB, Majoie CB. Systematic review of computed tomographic angiography for assessment of carotid artery disease. Stroke 2004; 35: 2306-12.
87. Addis KA, Hopper KD, Iyriboz TA et al. CT angiography: in vitro comparison of five reconstruction methods. AJR Am J Roentgenol 2001; 177: 1171-6.
88. Chen CJ, Lee TH, Hsu HL et al. Multi-slice CT angiography in diagnosing total versus near occlusions of the internal carotid artery: comparison with catheter angiography. Stroke 2004; 35: 83-5.
89. Rothwell PM, Eliasziw M, Gutnikov SA et al. Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet 2003; 361: 107-16.
90. King-Im JM, Trivedi RA, Cross JJ et al. Measuring carotid stenosis on contrast-enhanced magnetic resonance angiography: diagnostic performance and reproducibility of 3 different methods. Stroke 2004; 35: 2083-8.
91. Connors JJ III, Sacks D, Furlan AJ et al. Training, competency, and credentialing standards for diagnostic cervicocerebral angiography, carotid stenting, and cerebrovascular intervention: a joint statement from the American Academy of Neurology, American Association of Neurological Surgeons, American Society of Interventional and Therapeutic Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, AANS/CNS Cerebrovascular Section, and Society of Interventional Radiology. Radiology 2005; 234: 26-34.
92. Fayed AM, White CJ, Ramee SR, Jenkins JS, Collins TJ. Carotid and cerebral angiography performed by cardiologists: cerebrovascular complications. Catheter Cardiovasc Interv 2002; 55: 277-80.
93. Leonardi M, Cenni P, Simonetti L, Raffi L, Battaglia S. Retrospective study of complications arising during cerebral and spinal diagnostic angiography from 1998 to 2003. Interventional Neuroradiology 2005; 11: 213-21.
94. Smith S, Allen J. AHA/ACC secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2005 update. Circulation 2006; 113: 2363-72.
95. Sacco RL, Adams R, Albers G et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke 2006; 37: 577-617.
96. Eastern Stroke and Coronary Heart Disease Collaborative Research Group. Blood pressure, cholesterol, and stroke in eastern Asia. Lancet 1998; 352: 1801-7.
97. Vaccarino V, Berger AK, Abramson J et al. Pulse pressure and risk of cardiovascular events in the systolic hypertension in the elderly program. Am J Cardiol 2001; 88: 980-6.
98. Collins R, Peto R, MacMahon S et al. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990; 335: 827-38.
99. Staessen JA, Gasowski J, Wang JG et al. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet 2000; 355: 865-72.
100. Chobanian AV, Bakris GL, Black HR et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560-72.
101. Shinton R, Beevers G. Meta-analysis of relation between cigarette smoking and stroke. BMJ 1989; 298: 789-94.
102. Wolf PA, D' Agostino RB, Kannel WB, Bonita R, Belanger AJ. Cigarette smoking as a risk factor for stroke. The Framingham Study. JAMA 1988; 259: 1025-9.
103. You RX, Thrift AG, McNeil JJ, Davis SM, Donnan GA. Ischemic stroke risk and passive exposure to spouses' cigarette smoking. Melbourne Stroke Risk Factor Study (MERFS) Group. Am J Public Health 1999; 89: 572-5.
104. Kawachi I, Colditz GA, Stampfer MJ et al. Smoking cessation and decreased risk of stroke in women. JAMA 1993; 269: 232-6.
105. Fine-Edelstein JS, Wolf PA, O' Leary DH et al. Precursors of extracranial carotid atherosclerosis in the Framingham Study. Neurology 1994; 44: 1046-50.
106. Amarenco P, Lavallee P, Touboul PJ. Stroke prevention, blood cholesterol, and statins. Lancet Neurol 2004; 3: 271-8.
107. Kuller, LH, Dorman JS, Wolf PA. Cerebrovascular Disease and Diabetes. Bethesda, MD: NIH Publication # 85-1468, 1985.
108. Standards of medical care in diabetes. Diabetes Care 2004; 27(Suppl 1): S15-35.
109. Walker SP, Rimm EB, Ascherio A et al. Body size and fat distribution as predictors of stroke among US men. Am J Epidemiol 1996; 144: 1143-50.
110. Rexrode KM, Hennekens CH, Willett WC et al. A prospective study of body mass index, weight change, and risk of stroke in women. JAMA 1997; 277: 1539-45.
111. Wilhelmsen L, Svardsudd K, Korsan-Bengtsen K et al. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984; 311: 501-5.
112. Rost NS, Wolf PA, Kase CS et al. Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke 2001; 32: 2575-9.
113. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995; 274: 1049-57.
114. Further analyses of mortality in oral contraceptive users. Royal College of General Practitioners' Oral Contraception Study. Lancet 1981; 1: 541-6.
115. Wolf PA, D'Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: a risk profile from the Framingham Study. Stroke 1991; 22: 312-8.
116. The SALT Collaborative Group. Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events. Lancet 1991; 338: 1345-9.
117. Farrell B, Godwin J, Richards S, Warlow C. The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry 1991; 54: 1044-54.
118. The Dutch TIA Trial Study Group. A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke. N Engl J Med 1991; 325: 1261-6.
119. Taylor DW, Barnett HJ, Haynes RB et al. Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: a randomised controlled trial. ASA and Carotid Endarterectomy (ACE) Trial Collaborators. Lancet 1999; 353: 2179-84.
120. Diener HC, Cunha L, Forbes C et al. European stroke prevention study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996; 143: 1-13.
121. Halkes PH, van Gijn J, Kappelle LJ, Koudstaal PJ, Algra A. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet 2006; 367: 1665-73.
122. Gent M, Blakely JA, Easton JD et al. The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Lancet 1989; 1: 1215-20.
123. Hass WK, Easton JD, Adams HP Jr. et al. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group. N Engl J Med 1989; 321: 501-7.
124. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996; 348: 1329-39.
125. Diener HC, Bogousslavsky J, Brass LM et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet 2004; 364: 331-7.
126. Bhatt DL, Fox KA, Hacke W et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 2006; 354: 1706-17.
127. Mohr JP, Thompson JL, Lazar RM et al. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med 2001; 345: 1444-51.
128. Chimowitz MI, Kokkinos J, Strong J et al. The Warfarin-Aspirin Symptomatic Intracranial Disease Study. Neurology 1995; 45: 1488-93.
129. Ridker PM, Cook NR, Lee IM et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 2005; 352: 1293-304.
130. Antithrombotic Trialists Collaboration. Collaborative metaanalysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002; 324: 71-86.
131. Albers GW, Amarenco P, Easton JD et al. Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 483S-512S.
132. Rubins HB, Robins SJ, Collins D et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans affairs high-density Lipoprotein Cholesterol intervention Trial Study Group. N Engl J Med 1999; 341: 410-8.
133. Canner PL, Berge KG, Wenger NK et al. Fifteen year mortality in coronary drug project patients: long-term benefit with niacin. J Am Coll Cardiol 1986; 8: 1245-55.
134. Collins R, Armitage J, Parish S et al. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions. Lancet 2004; 363: 757-67.
135. Sever PS, Dahlof B, Poulter NR et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet 2003; 361: 1149-58.
136. White HD, Simes RJ, Anderson NE et al. Pravastatin therapy and the risk of stroke. N Engl J Med 2000; 343: 317-26.
137. McGirt MJ, Perler BA, Brooke BS et al. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors reduce the risk of perioperative stroke and mortality after carotid endarterectomy. J Vasc Surg 2005; 42: 829-36.
138. Amarenco P, Bogousslavsky J, Callahan A et al. Design and baseline characteristics of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) study. Cerebrovasc Dis 2003; 16: 389-95.
139. Amarenco P, Bogousslavsky J, Callahan AS III et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006; 355: 549-59.
140. Grundy SM, Cleeman JI, Merz CN et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004; 110: 227-39.
141. Statins after ischemic stroke and transient ischemic attack: an advisory statement from the Stroke Council, American Heart Association and American Stroke Association. Stroke 2004; 35: 1023
142. Yusuf S, Sleight P, Pogue J et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000; 342: 145-53.
143. Lonn E, Yusuf S, Dzavik V et al. Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE). Circulation 2001; 103: 919-25.
144. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001; 358: 1033-41.
145. Lindholm LH, Ibsen H, Dahlof B et al. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002; 359: 1004-10.
146. Fisher M. Occlusion of the internal carotid artery. AMA Arch Neurol Psychiatry 1951; 65: 346-77.
147. DeBakey ME. Successful carotid endarterectomy for cerebrovascular insufficiency. Nineteen-year follow-up. JAMA 1975; 233: 1083-5.
148. Eastcott HH, Pickering GW, Rob CG. Reconstruction of internal carotid artery in a patient with intermittent attacks of hemiplegia. Lancet 1954; 267: 994-6.
149. The EC/IC Bypass Study Group. Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. Results of an international randomized trial. N Engl J Med 1985; 313: 1191-200.
150. Chambers BR, Norris JW. The case against surgery for asymptomatic carotid stenosis. Stroke 1984; 15: 964-7.
151. Mayberg MR, Wilson SE, Yatsu F et al. Carotid endarterectomy and prevention of cerebral ischemia in symptomatic carotid stenosis. Veterans affairs cooperative studies program 309 trialist group. JAMA 1991; 266: 3289-94.
152. Hobson RW, Weiss DG, Fields WS et al. Efficacy of carotid endarterectomy for asymptomatic carotid stenosis. The veterans affairs cooperative study group. N Engl J Med 1993; 328: 221-7.
153. Tangkanakul C, Counsell CE, Warlow CP. Local versus general anaesthesia in carotid endarterectomy: a systematic review of the evidence. Eur J Vasc Endovasc Surg 1997; 13: 491-9.
154. Cao P, De Rango P, Zannetti S. Eversion vs conventional carotid endarterectomy: a systematic review. Eur J Vasc Endovasc Surg 2002; 23: 195-201.
155. Ferguson GG, Eliasziw M, Barr HW et al. The North American Symptomatic Carotid Endarterectomy Trial: surgical results in 1415 patients. Stroke 1999; 30: 1751-8.
156. Baker WH, Littooy FN, Hayes AC, Dorner DB, Stubbs D. Carotid endarterectomy without a shunt: the control series. J Vasc Surg 1984; 1: 50-6.
157. Gnanadev DA, Wang N, Comunale FL, Reile DA. Carotid artery stump pressure: how reliable is it in predicting the need for a shunt? Ann Vasc Surg 1989; 3: 313-7.
158. Schneider JR, Droste JS, Schindler N et al. Carotid endarterectomy with routine electroencephalography and selective shunting: influence of contralateral internal carotid artery occlusion and utility in prevention of perioperative strokes. J Vasc Surg 2002; 35: 1114-22.
159. Counsell CE, Salinas R, Naylor R, Warlow CP. A systematic review of the randomised trials of carotid patch angioplasty in carotid endarterectomy. Eur J Vasc Endovasc Surg 1997; 13: 345-54.
160. Ouriel K, Green RM. Clinical and technical factors influencing recurrent carotid stenosis and occlusion after endarterectomy. J Vasc Surg 1987; 5: 702-6.
161. Grego F, Antonello M, Lepidi S et al. Prospective, randomized study of external jugular vein patch versus polytetrafluoroethylene patch during carotid endarterectomy: perioperative and long-term results. J Vasc Surg 2003; 38: 1232-40.
162. O' Hara PJ, Hertzer NR, Mascha EJ et al. A prospective, randomized study of saphenous vein patching versus synthetic patching during carotid endarterectomy. J Vasc Surg 2002; 35: 324-32.
163. Bond R, Rerkasem K, Rothwell PM. Systematic review of the risks of carotid endarterectomy in relation to the clinical indication for and timing of surgery. Stroke 2003; 34: 2290-301.
164. Bond R, Rerkasem K, Shearman CP, Rothwell PM. Time trends in the published risks of stroke and death due to endarterectomy for symptomatic carotid stenosis. Cerebrovasc Dis 2004; 18: 37-46.
165. Feasby TE, Quan H, Ghali WA. Hospital and surgeon determinants of carotid endarterectomy outcomes. Arch Neurol 2002; 59: 1877-81.
166. Pearce WH, Parker MA, Feinglass J, Ujiki M, Manheim LM. The importance of surgeon volume and training in outcomes for vascular surgical procedures. J Vasc Surg 1999; 29: 768-76.
167. Chambers B, Donnan G, Chambers B. Carotid endarterectomy for asymptomatic carotid stenosis. Cochrane Database Syst Rev 2005; CD001923.
168. Barnett HJ, Eliasziw M, Meldrum HE, Taylor DW. Do the facts and figures warrant a 10-fold increase in the performance of carotid endarterectomy on asymptomatic patients? Neurology 1996; 46: 603-8.
169. Hsia DC, Moscoe LM, Krushat WM. Epidemiology of carotid endarterectomy among Medicare beneficiaries: 1985-1996 update. Stroke 1998; 29: 346-50.
170. Wennberg DE, Lucas FL, Birkmeyer JD, Bredenberg CE, Fisher ES. Variation in carotid endarterectomy mortality in the Medicare population: trial hospitals, volume, and patient characteristics. JAMA 1998; 279: 1278-81.
171. Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study
172. Yadav JS, Wholey MH, Kuntz RE et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 2004; 351: 1493-501.
173. Chaturvedi S. Should the multicenter carotid endarterectomy trials be repeated? Arch Neurol 2003; 60: 774-5.
174. Rothwell PM, Slattery J, Warlow CP. A systematic review of the risks of stroke and death due to endarterectomy for symptomatic carotid stenosis. Stroke 1996; 27: 260-5.
175. Biller J, Feinberg WM, Castaldo JE et al. Guidelines for carotid endarterectomy: a statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. Circulation 1998; 97: 501-9.
176. Chaturvedi S, Bruno A, Feasby T et al. Carotid endarterectomy - an evidence-based review: report of the Therapeutics and technology assessment subcommittee of the American Academy of Neurology. Neurology 2005; 65: 794-801.
177. Rothwell PM, Eliasziw M, Gutnikov SA, Warlow CP, Barnett HJ. Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet 2004; 363: 915-24.
178. Bockenheimer SA, Mathias K. Percutaneous transluminal angioplasty in arteriosclerotic internal carotid artery stenosis. Am J Neuroradiol 1983; 4: 791-2.
179. Theron J, Raymond J, Casasco A, Courtheoux F. Percutaneous angioplasty of atherosclerotic and postsurgical stenosis of carotid arteries. Am J Neuroradiol 1987; 8: 495-500.
180. Theron J, Courtheoux P, Alachkar F, Bouvard G, Maiza D. New triple coaxial catheter system for carotid angioplasty with cerebral protection. Am J Neuroradiol 1990; 11: 869-74.
181. Wiggli U, Gratzl O. Transluminal angioplasty of stenotic carotid arteries: case reports and protocol. Am J Neuroradiol 1983; 4: 793-5.
182. Diethrich EB, Ndiaye M, Reid DB. Stenting in the carotid artery: initial experience in 110 patients. J Endovasc Surg 1996; 3: 42-62.
183. Marks MP, Dake MD, Steinberg UK, Norbash AM, Lane B. Stent placement for arterial and venous cerebrovascular disease: preliminary experience. Radiology 1994; 191: 441-6.
184. Roubin GS, New G, Iyer SS et al. Immediate and late clinical outcomes of carotid artery stenting in patients with symptomatic and asymptomatic carotid artery stenosis: a 5-year prospective analysis. Circulation 2001; 103: 532-7.
185. Kastrup A, Groschel K, Krapf H et al. Early outcome of carotid angioplasty and stenting with and without cerebral protection devices: a systematic review of the literature. Stroke 2003; 34: 813-9.
186. Wholey MH, Al-Mubarek N, Wholey MH. Updated review of the global carotid artery stent registry. Catheter Cardiovasc Interv 2003; 60: 259-66.
187. Theiss W, Hermanek P, Mathias K et al. Pro-CAS: a prospective registry of carotid angioplasty and stenting. Stroke 2004; 35: 2134-9.
188. Bosiers M, Peeters P, Deloose K et al. Does carotid artery stenting work on the long run: 5-year results in high-volume centers (ELOCAS Registry). J Cardiovasc Surg (Torino) 2005; 46: 241-7.
189. White CJ, Iyer SS, Hopkins LN, Katzen BT, Russell ME. Carotid stenting with distal protection in high surgical risk patients: the BEACH trial 30 day results. Catheter Cardiovasc Interv 2006; 67: 503-12.
190. Safian RD, Bresnahan JF, Jaff MR et al. Protected carotid stenting in high-risk patients with severe carotid artery stenosis. J Am Coll Cardiol 2006; 47: 2384-9.
191. Gray WA, Hopkins LN, Yadav S et al. Protected carotid stenting in high surgical risk patients: the ARCHeR results. J Vasc Surg 2006; 44: 258-68.
192. Ramee S, Higashida R. Evaluation of the Medtronic self-expanding carotid stent system with distal protection in the treatment of carotid artery stenosis: the MAVErIC Trial Phase II 30-day update. (abstr) Am J Cardiol 2004; 94: 61E.
193. Hopkins LN. CABERNET. Oral presentation, EuroPCR Conference in Paris, France, May 26, 2005.
194. Gray WA. ARCHeR. Oral presentation, Amerian College of Cardiology Annual Scientific Session, Alanta, GA, March 2006.
195. Naylor AR, Bolia A, Abbott RJ et al. Randomized study of carotid angioplasty and stenting versus carotid endarterectomy: a stopped trial. J Vasc Surg 1998; 28: 326-34.
196. Alberts M. Results of a multicenter prospective randomized trial of carotid artery stenting vs. carotid endarterectomy. (abstr)Stroke 2001; 32: 325d.
197. Brooks WH, McClure RR, Jones MR et al. Carotid angioplasty and stenting versus carotid endarterectomy: randomized trial in a community hospital. J Am Coll Cardiol 2001; 38: 1589-95.
198. Brooks WH, McClure RR, Jones MR et al. Carotid angioplasty and stenting versus carotid endarterectomy for treatment of asymptomatic carotid stenosis: a randomized trial in a community hospital. Neurosurgery 2004; 54: 318-24.
199. Yadav JS, Sneed D, Ouriel K et al. Durability of carotid stenting for the prevention of stroke: 3-year follow-up of the SAPPHIRE trial and the US Carotid Feasibility. (abstr) Circulation 2005; 112(Suppl:II): 416.
200. Coward LJ, Featherstone RL, Brown MM. Safety and efficacy of endovascular treatment of carotid artery stenosis compared with carotid endarterectomy: a Cochrane systematic review of the randomized evidence. Stroke 2005; 36: 905-11.
201. Ringleb PA, Kunze A, Allenberg JR et al. The Stent-Supported Percutaneous Angioplasty of the Carotid Artery vs. Endarterectomy Trial. Cerebrovasc Dis 2004; 18: 66-8.
202. Ringleb PA, Allenberg JR, Bruckmann H et al. 30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial. Lancet 2006; 368: 1215-6.
203. EVA-3S Investigators. Endarterectomy vs. Angioplasty in Patients with Symptomatic Severe Carotid Stenosis (EVA-3S) trial. Cerebrovasc Dis 2004; 18: 62-5.
204. Mas JL, Chatellier G, Beyssen B. Carotid angioplasty and stenting with and without cerebral protection: clinical alert from the Endarterectomy Versus Angioplasty in Patients With Symptomatic Severe Carotid Stenosis (EVA-3S) trial. Stroke 2004; 35: e18-e20.
205. Mas JL, Chatellier G, Beyssen B et al. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med 2006; 355: 1726-9.
206. Featherstone RL, Brown MM, Coward LJ. International carotid stenting study: protocol for a randomised clinical trial comparing carotid stenting with endarterectomy in symptomatic carotid artery stenosis. Cerebrovasc Dis 2004; 18: 69-74.
207. Hobson RW. CREST (Carotid Revascularization Endarterectomy versus Stent Trial): background, design, and current status. Semin Vasc Surg 2000; 13: 139-43.
208. Hobson RW, Howard VJ, Roubin GS et al. Carotid artery stenting is associated with increased complications in octogenarians: 30-day stroke and death rates in the CREST lead-in phase. J Vasc Surg 2004; 40: 1106-11.
209. CARESS Steering Committee. Carotid revascularization using endarterectomy or stenting systems (CARESS): phase I clinical trial. J Endovasc Ther 2003; 10: 1021-30.
210. CaRESS Steering Committee. Carotid Revascularization Using Endarterectomy or Stenting Systems (CaRESS) phase I clinical trial: 1-year results. J Vasc Surg 2005; 42: 213-9.
211. Schievink WI. Spontaneous dissection of the carotid and vertebral arteries. N Engl J Med 2001; 344: 898-906.
212. Cohen JE, Leker RR, Gotkine M, Gomori M, Ben-Hur T. Emergent stenting to treat patients with carotid artery dissection: clinically and radiologically directed therapeutic decision making. Stroke 2003; 34: e254-e257.
213. Houdart E, Mounayer C, Chapot R, Saint-Maurice JP, Merland JJ. Carotid stenting for radiation-induced stenoses: a report of 7 cases. Stroke 2001; 32: 118-21.
214. Finsterer J, Strassegger J, Haymerle A, Hagmuller G. Bilateral stenting of symptomatic and asymptomatic internal carotid artery stenosis due to fibromuscular dysplasia. J Neurol Neurosurg Psychiatry 2000; 69: 683-6.
215. Sharma BK, Jain S, Bali HK, Jain A, Kumari S. A follow-up study of balloon angioplasty and de-novo stenting in Takayasu arteritis. Int J Cardiol 2000; 75(Suppl 1): S147-S152.
216. Roubin GS, Iyer S, Halkin A, Vitek J, Brennan C. Realizing the potential of carotid artery stenting: proposed paradigms for patient selection and procedural technique. Circulation 2006; 113: 2021-30.
217. Blacker DJ, Flemming KD, Link MJ, Brown RD Jr. The preoperative cerebrovascular consultation: common cerebrovascular questions before general or cardiac surgery. Mayo Clin Proc 2004; 79: 223-9.
218. Stanziale SF, Marone LK, Boules TN et al. Carotid artery stenting in octogenarians is associated with increased adverse outcomes. J Vasc Surg 2006; 43: 297-304.
219. Naylor AR, Mehta Z, Rothwell PM, Bell PR. Carotid artery disease and stroke during coronary artery bypass: a critical review of the literature. Eur J Vasc Endovasc Surg 2002; 23: 283-94.
220. Kasner SE, Chimowitz MI, Lynn MJ et al. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation 2006; 113: 555-63.
221. Bush RL, Lin PH, Mureebe L et al. Routine bivalirudin use in percutaneous carotid interventions. J Endovasc Ther 2005; 12: 521-2.
222. Kapadia SR, Bajzer CT, Ziada KM et al. Initial experience of platelet glycoprotein IIb/IIIa inhibition with abciximab during carotid stenting: a safe and effective adjunctive therapy. Stroke 2001; 32: 2328-32.
223. Wholey MH, Wholey MH, Eles G et al. Evaluation of glycoprotein IIb/IIIa inhibitors in carotid angioplasty and stenting. J Endovasc Ther 2003; 10: 33-41.
224. Rosenfield K, Babb JD, Cates CU et al. Clinical competence statement on carotid stenting: training and credentialing for carotid stenting - multispecialty consensus recommendations: a report of the SCAI/SVMB/SVS Writing Committee to Develop a Clinical Competence Statement on Carotid Interventions. J Am Coll Cardiol 2005; 45: 165-74.
225. Barr JD, Connors JJ III, Sacks D et al. Quality improvement guidelines for the performance of cervical carotid angioplasty and stent placement. J Vasc Interv Radiol 2003; 14: S321-S335.
226. Beller GA, Bonow RO, Fuster V. ACC revised recommendations for training in adult cardiovascular medicine. Core Cardiology Training II (COCATS 2). (Revision of the 1995 COCATS training statement). J Am Coll Cardiol 2002; 39: 1242-6.
227. Creager MA, Goldstone J, Hirshfeld JW Jr. et al. ACC/ACP/SCAI/SVMB/SVS clinical competence statement on vascular medicine and catheter-based peripheral vascular interventions: a report of the American College of Cardiology/American Heart Association/American College of Physician Task Force on Clinical Competence (ACC/ACP/SCAI/SVMB/SVS Writing Committee to Develop a Clinical Competence Statement on Peripheral Vascular Disease). J Am Coll Cardiol 2004; 44: 941-57.
228. Seymour NE, Gallagher AG, Roman SA et al. Virtual reality training improves operating room performance: results of a randomized, double-blinded study. Ann Surg 2002; 236: 458-63.
229. Patel A, Gallagher A, Nicholson W, Cates CU. Learning curves and reliability measures for virtual reality simulation in the performance assessment of carotid angiography. J Am Coll Cardiol 2006; 47: 1796-802.